Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GABBR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANAPC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLE4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BIRC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRAIC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IGFBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTBK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OIP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASRGL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRIM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMOTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM172A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDV3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on